Millions of people with asthma use the blue inhaler to help relieve the symptoms when they have an attack but a doctor is now warning of 'dangerous' sign ...
Efficacy and Safety of Sotatercept in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Connective Tissue Disease (CTD): A Pooled Analysis From STELLAR, ZENITH, and HYPERION,” new ...
Not intended for US and UK media Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are life-threatening, progressive ...
MannKind’s Afrezza wins FDA approval for pediatric use—unlocking growth and a $300–500M opportunity. Read here for more on ...
10:29, Tue, May 5, 2026 Updated: 10:36, Tue, May 5, 2026 Asthma sufferers who rely on a blue inhaler to manage their condition are being advised to speak to their GP. The guidance follows updated ...
Idiopathic pulmonary fibrosis slowly turns the lungs stiff and scarred, but researchers may have found why the damage keeps ...
This Cystic Fibrosis Awareness Month, Children's Hospital Colorado (Children's Colorado) is highlighting a growing shift in ...
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...
The earliest stages of lung cancer could be uncovered by a simple urine test which could be available for NHS use in just ...
The Motley Fool has been providing investing insights and personal finance to millions of people for over 25 years. Learn how we make the world Smarter, Happier ...
Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results